Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, has signed a Memorandum of Understanding (MOU) with ESCO Aster, a vertically-integrated contract manufacturing organization, to produce cultivated meat in Singapore.
In addition to Israel, Singapore is one of the first two markets where Aleph Farm intends to launch its cultivated thin-cut steak. According to the company, building up production capacity quickly in Singapore while keeping capital investment lean provides a clear roadmap to scalability. Notably, ESCO Aster has obtained full regulatory approval from the Singapore Food Agency to produce cultivated meat for commercial sales and consumption.
The MOU covers the use of ESCO Aster’s manufacturing expertise in producing Aleph Farms’ cultivated meat in Singapore. The agreement stands to increase Aleph Farms’ production capabilities and global impact as the company approaches commercialization. The company plans to produce different cuts of steak and other products based on animal cells, such as cultivated collagen, through additional proprietary capabilities. From a single fertilized egg, Aleph Farms can grow thousands of tons of cultivated meat, serving as part of a just and inclusive transition to sustainable and secure food systems.
(Source: Aleph Farms)
